Clinical Trial

Thymosin-α1 for Recurrent Implantation Failure

Name: Thymosin-α1 for Recurrent Implantation Failure — clinical trial record (NCT07675980)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Thy-α1 for RIF

Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

Clinical trial evaluating the safety and efficacy of Thymosin-α1 (Tα1) as an adjunctive immunomodulatory therapy in women with unexplained recurrent implantation failure (RIF) undergoing IVF/ICSI cycles.

Trial Details

NCT Number	NCT07675980
Lead Sponsor	Fakih IVF Fertility Center
Conditions	Recurrent Implantation Faliure
Enrollment	136 participants
Start Date	2026-02-11
Primary Completion	2027-02 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2026-06-30